Mobile health ethics and the expanding role of autonomy.Bettina Schmietow &Georg Marckmann -2019 -Medicine, Health Care and Philosophy 22 (4):623-630.detailsMhealth technology is mushrooming world-wide and, in a variety of forms, reaches increasing numbers of users in ever-widening contexts and virtually independent from standard medical evidence assessment. Yet, debate on the broader societal impact including in particular mapping and classification of ethical issues raised has been limited. This article, as part of an ongoing empirically informed ethical research project, provides an overview of ethical issues of mhealth applications with a specific focus on implications on autonomy as a key notion in (...) the debate. A multi-stage model of references to the potential of mhealth use for strengthening some or other form of self-determination will be proposed as a descriptive tool. It illustrates an assumed continuum of enhanced autonomy via mhealth broadly conceived: from patient to user autonomy, to improved health literacy, and finally to the vision of supra-individual empowerment and democratised, participatory health and medicine as a whole. On closer examination, however, these references are frequently ambivalent or vague, perpetuating the at times uncritical use of established autonomy concepts in medical ethics. The article suggests zooming in on the range of autonomy-related aspects against the backdrop of digital innovation and datafied health more generally, and on this basis add to existing frameworks for the ethical evaluation of mhealth more specifically. (shrink)
Ökonomisierung im Gesundheitswesen als organisationsethische Herausforderung.Georg Marckmann -2021 -Ethik in der Medizin 33 (2):189-201.detailsDer finanzielle Druck auf die Krankenhäuser in Deutschland führt zu einer Ökonomisierung medizinischer Entscheidungen, die die Qualität der Patientenversorgung beeinträchtigt und das Gesundheitspersonal erheblich belastet. Der vorliegende Beitrag untersucht, welche Möglichkeiten ein organisationsethischer Ansatz bietet, den Herausforderungen durch die Ökonomisierung zu begegnen. Ausgewählte empirische Befunde sollen zunächst verdeutlichen, welche Auswirkungen die Ökonomisierung auf die Patientenversorgung und das Personal in den Krankenhäusern hat. Zudem liefern sie erste Hinweise auf mögliche Handlungsspielräume für die Krankenhäuser. Dabei wird deutlich, dass die Ökonomisierung einen organisationsethischen (...) Ansatz erfordert, der die Handlungsspielräume auf der Mesoebene, d. h. auf der Ebene der einzelnen Krankenhäuser nutzt. Der organisationsethische Ansatz wird in seinen Grundzügen vorgestellt und dann im Sinne eines Wertemanagements als Lösungsperspektive für die Herausforderungen der Ökonomisierung konkretisiert. Abschließend entwickelt der Beitrag Perspektiven, wie klinische Ethikkomitees mit organisationsethischer Arbeit den negativen Auswirkungen der Ökonomisierung auf die Patientenversorgung und das Personal im Krankenhaus entgegenwirken können. (shrink)
No categories
Digital contact tracing and exposure notification: ethical guidance for trustworthy pandemic management.Robert Ranisch,Niels Nijsingh,Angela Ballantyne,Anne van Bergen,Alena Buyx,Orsolya Friedrich,Tereza Hendl,Georg Marckmann,Christian Munthe &Verina Wild -2020 -Ethics and Information Technology 23 (3):285-294.detailsThere is growing interest in contact tracing apps for pandemic management. It is crucial to consider ethical requirements before, while, and after implementing such apps. In this paper, we illustrate the complexity and multiplicity of the ethical considerations by presenting an ethical framework for a responsible design and implementation of CT apps. Using this framework as a starting point, we briefly highlight the interconnection of social and political contexts, available measures of pandemic management, and a multi-layer assessment of CT apps. (...) We will discuss some trade-offs that arise from this perspective. We then suggest that public trust is of major importance for population uptake of contact tracing apps. Hasty, ill-prepared or badly communicated implementations of CT apps will likely undermine public trust, and as such, risk impeding general effectiveness. (shrink)
Who shall go first? A multicriteria approach to patient selection for first clinical trials of cardiac xenotransplantation.Johannes Kögel,Michael Schmoeckel &Georg Marckmann -2025 -Journal of Medical Ethics 51 (3):156-162.detailsAfter achieving sustained graft functioning in animal studies, the next step in the progression of xenotransplantation towards clinical application is the initiation of the first clinical trials. This raises the question according to which criteria patients shall be selected for these trials. While the discussion regarding medical criteria has already commenced, ethical considerations must also be taken into account. This is essential, first, to establish a procedure that is ethically reasonable and justified. Second, it is a prerequisite for a publicly (...) acceptable and comprehensible implementation. This paper outlines a multicriteria approach for the selection of patients in first-in-human clinical trials of cardiac xenotransplantation with four ethical criteria: medical need, capacity to benefit, patient choice and compliance (as an exclusion criterion). Consequently, these criteria identify a primary target group of patients who exhibit a high medical need for cardiac xenotransplantation, face a high risk of morbidity and mortality without an organ replcaement therapy, have a substantial chance of benefiting from xenotransplantation, thereby also enhancing the scientific value of the trial, and qualify for an allotransplant to have a real choice between participating in a first-in-human xenotransplantation trial and waiting for a human organ. A secondary group would include patients for whom only the first two criteria are met, that is, who have a high medical need and a good capacity to benefit from xenotransplantation but who have a restricted choice because they do not qualify for an allotransplant. (shrink)
Principle-based structured case discussions: do they foster moral competence in medical students? - A pilot study.Orsolya Friedrich,Kay Hemmerling,Katja Kuehlmeyer,Stefanie Nörtemann,Martin Fischer &Georg Marckmann -2017 -BMC Medical Ethics 18 (1):21.detailsRecent findings suggest that medical students’ moral competence decreases throughout medical school. This pilot study gives preliminary insights into the effects of two educational interventions in ethics classes on moral competence among medical students in Munich, Germany. Between 2012 and 2013, medical students were tested using Lind’s Moral Competence Test prior to and after completing different ethics classes. The experimental group participated in principle-based structured case discussions and was compared with a control group with theory-based case discussions. The pre/post C-scores (...) were compared using a Wilcoxon Test, ANOVA and effect-size calculation. The C-score improved by around 3.2 C-points in the EG, and by 0.2 C-points in the CG. The mean C-score difference was not statistically significant for the EG or between the two groups. There was no statistical significance for the teachers’ influence on C-score. In both groups, students with below-average C-scores improved and students with above-average C-scores regressed. The increase of the C-Index was greater in the EG than in the CG. The absolute effect-size of the EG compared with the CG was 3.0 C-points, indicating a relevant effect. Teaching ethics with PBSCDs did not provide a statistically significant influence on students’ moral competence, compared with TBCDs. Yet, the effect size suggests that PBSCDs may improve moral competence among medical students more effectively. Further research with larger and completely randomized samples is needed to gain definite explanations for the results. (shrink)
Are physicians willing to ration health care? Conflicting findings in a systematic review of survey research.Daniel Strech,Govind Persad,Georg Marckmann &Marion Danis -2009 -Health Policy 90 (2):113-124.detailsSeveral quantitative surveys have been conducted internationally to gather empirical information about physicians’ general attitudes towards health care rationing. Are physicians ready to accept and implement rationing, or are they rather reluctant? Do they prefer implicit bedside rationing that allows the physician–patient relationship broad leeway in individual decisions? Or do physicians prefer strategies that apply explicit criteria and rules?
(1 other version)What is personalized medicine: sharpening a vague term based on a systematic literature review.Sebastian Schleidgen &Georg Marckmann -2013 -BMC Medical Ethics 14 (1):20.detailsIn recent years, personalized medicine (PM) has become a highly regarded line of development in medicine. Yet, it is still a relatively new field. As a consequence, the discussion of its future developments, in particular of its ethical implications, in most cases can only be anticipative. Such anticipative discussions, however, pose several challenges. Nevertheless, they play a crucial role for shaping PM’s further developments. Therefore, it is vital to understand how the ethical discourse on PM is conducted, i.e. on what (...) – empirical and normative – assumptions ethical arguments are based regarding PM’s current and future developments. (shrink)
Medical futility at the end of life: the perspectives of intensive care and palliative care clinicians.Ralf J. Jox,Andreas Schaider,Georg Marckmann &Gian Domenico Borasio -2012 -Journal of Medical Ethics 38 (9):540-545.detailsObjectives Medical futility at the end of life is a growing challenge to medicine. The goals of the authors were to elucidate how clinicians define futility, when they perceive life-sustaining treatment (LST) to be futile, how they communicate this situation and why LST is sometimes continued despite being recognised as futile. Methods The authors reviewed ethics case consultation protocols and conducted semi-structured interviews with 18 physicians and 11 nurses from adult intensive and palliative care units at a tertiary hospital in (...) Germany. The transcripts were subjected to qualitative content analysis. Results Futility was identified in the majority of case consultations. Interviewees associated futility with the failure to achieve goals of care that offer a benefit to the patient's quality of life and are proportionate to the risks, harms and costs. Prototypic examples mentioned are situations of irreversible dependence on LST, advanced metastatic malignancies and extensive brain injury. Participants agreed that futility should be assessed by physicians after consultation with the care team. Intensivists favoured an indirect and stepwise disclosure of the prognosis. Palliative care clinicians focused on a candid and empathetic information strategy. The reasons for continuing futile LST are primarily emotional, such as guilt, grief, fear of legal consequences and concerns about the family's reaction. Other obstacles are organisational routines, insufficient legal and palliative knowledge and treatment requests by patients or families. Conclusion Managing futility could be improved by communication training, knowledge transfer, organisational improvements and emotional and ethical support systems. The authors propose an algorithm for end-of-life decision making focusing on goals of treatment. (shrink)
Evaluating a patient's request for life-prolonging treatment: an ethical framework.Eva C. Winkler,Wolfgang Hiddemann &Georg Marckmann -2012 -Journal of Medical Ethics 38 (11):647-651.detailsContrary to the widespread concern about over-treatment at the end of life, today, patient preferences for palliative care at the end of life are frequently respected. However, ethically challenging situations in the current healthcare climate are, instead, situations in which a competent patient requests active treatment with the goal of life-prolongation while the physician suggests best supportive care only. The argument of futility has often been used to justify unilateral decisions made by physicians to withhold or withdraw life-sustaining treatment. However, (...) we argue that neither the concept of futility nor that of patient autonomy alone is apt for resolving situations in which physicians are confronted with patients' requests for active treatment. Instead, we integrate the relevant arguments that have been put forward in the academic discussion about ‘futile’ treatment into an ethical algorithm with five guiding questions: (1) Is there a chance that medical intervention will be effective in achieving the patient's treatment goal? (2) How does the physician evaluate the expected benefit and the potential harm of the treatment? (3) Does the patient understand his or her medical situation? (4) Does the patient prefer receiving treatment after evaluating the benefit-harm ratio and the costs? (5) Does the treatment require many resources? This algorithm shall facilitate approaching patients' requests for treatments deemed futile by the physician in a systematic way, and responding to these requests in an ethically appropriate manner. It thereby adds substantive considerations to the current procedural approaches of conflict resolution in order to improve decision making among physicians, patients and families. (shrink)
Möglichkeiten und Grenzen von Ethikberatung im Rahmen der COVID-19-Pandemie.Georg Marckmann,Gerald Neitzke,Annette Riedel,Silke Schicktanz,Jan Schildmann,Alfred Simon,Ralf Stoecker,Jochen Vollmann,Eva Winkler &Christin Zang -2020 -Ethik in der Medizin 32 (2):195-199.detailsDas deutsche Gesundheitswesen steht durch die schnell steigende Anzahl an CO- VID-19-Erkrankten vor erheblichen Herausforderungen. In dieser Krisensituation sind alle Beteiligten mit ethischen Fragen konfrontiert, beispielsweise nach gerech- ten Verteilungskriterien bei begrenzten Ressourcen und dem gesundheitlichen Schutz des Personals angesichts einer bisher nicht therapierbaren Erkrankung. Daher werden schon jetzt klinische und ambulante Ethikberatungsangebote verstärkt mit Anfragen nach Unterstützung konfrontiert. Wie können Ethikberater*innen Entscheidungen in der Krankenversorgung im Rahmen der COVID-19-Pandemie unterstützen? Welche Grenzen von Ethikberatung sind zu beachten? Bislang liegen hierzu (...) noch wenige praktische Erfahrungen vor. Angesichts der dynamischen Entwicklung erscheint es der Akademie für Ethik in der Medizin (AEM) wichtig, einen Diskurs über die angemessene Rolle der Ethikberatung bei der Bewältigung der vielfachen Heraus- forderungen durch die COVID-19-Pandemie zu führen und professionelle Hinweise zu geben. Mit dem vorliegenden Diskussionspapier möchte die AEM einen Beitrag zur Beantwortung wesentlicher Fragen leisten, die sich für die Ethikberatung in den verschiedenen Bereichen des Gesundheitswesens stellen. Sie regt an, diesen Dis- kurs weiter zu führen und hat ein Online-Forum (s. unten) eingerichtet, in dem Ethikberater*innen ihre Erfahrungen teilen und die professionelle Selbstreflexion der Ethikberatung in Pandemiezeiten mit Anregungen fördern können. (shrink)
Transformative medical ethics: A framework for changing practice according to normative–ethical requirements.Katja Kuehlmeyer,Bianca Jansky,Marcel Mertz &Georg Marckmann -2023 -Bioethics 38 (3):241-251.detailsWe propose a step‐by‐step methodological framework of translational bioethics that aims at changing medical practice according to normative–ethical requirements, which we will thus call “transformative medical ethics.” The framework becomes especially important when there is a gap between widely acknowledged, ethically justified normative claims and their realization in the practice of biomedicine and technology (ought–is gap). Building on prior work on translational bioethics, the framework maps a process with six different phases and 12 distinct translational steps. The steps involve various (...) research activities including conceptual philosophical inquiry and (socio‐)empirical research. On the one hand, the framework can be used as a heuristic tool to identify barriers to the transformation process. On the other hand, it can provide guidance for researchers and practitioners to develop appropriate (conceptual action and practice) models, which are then implemented and evaluated in specific practice contexts. We use the example of realizing the norm of respect for autonomy in the practice of medical decision‐making to illustrate the framework. Further research is required, for example, to theoretically underpin the framework, to apply it to other ought–is gaps, and to evaluate its feasibility and effectiveness in various practice areas. Overall, the framework of transformative medical ethics suggests a strategic process to investigate and promote practice change that is ethically informed in all phases. (shrink)
Patient choice as inclusion criterion for first clinical trials of xenotransplantation.Johannes Kögel,Michael Schmoeckel &Georg Marckmann -2025 -Journal of Medical Ethics 51 (3):172-173.detailsWe are grateful for the thoughtful commentaries to our article on patient selection for first clinical trials of cardiac xenotransplantation1 because they give us the opportunity to clarify and further sharpen our arguments in this response. In our article, we proposed a multicriteria approach to selecting patients for first clinical trials of (cardiac) xenotransplantation, encompassing the four criteria medical need, capacity to benefit, patient choice and compliance (used as an exclusion criterion). We also argued that clinical trials following clearly defined (...) study protocols should be favoured over further single compassionate use cases to gather reliable and valid knowledge about the benefits and risks of xenotransplantation. Continuous poor outcomes in compassionate use cases can impede a technology’s development. For example, early heart transplants led to moratoria in several countries due to public and professional backlash. This historical concern is also echoed within the xenotransplantation research community and should be considered when arguing, as Aparicio et al do in their comment, for continuing the expanded access pathway to further establish clinical xenotransplantation.2 We agree with Aparicio et al that patients in general should have access to innovative treatment strategies via expanded access. In cardiac xenotransplantation, however, only a small number of patients can currently be offered a xenotransplant because of limited treatment capacities with …. (shrink)
Competency-oriented teaching of ethics in medical schools.Katja Kühlmeyer,Andreas Wolkenstein,Mathias Schütz,Verina Wild &Georg Marckmann -2022 -Ethik in der Medizin 34 (3):301-318.detailsDefinition of the problemThe upcoming reforms according to the specifications of the Master Plan 2020 provide for a competency-oriented restructuring of medical studies. This article aims to develop perspectives on how teaching ethics in medical studies can be more strongly oriented at building competencies. In this way, it pursues the goal of making the concept of competency more tangible for medical ethics and usable for the design of medical ethics education.ArgumentsWe understand competencies as dispositions for actions that enable problem solving. (...) By transferring the concept of moral intelligence to the moral actions of physicians in patient care, we specify five ethical–moral competencies that must be present for morally appropriate, ethically reflected actions by future physicians: (1) the ability to form a professional moral compass, (2) the willingness to align oneself with professional ethical norms and values, (3) the ability to perceive moral dimensions of medical action, (4) the ability to make moral judgments based on ethical considerations about the right action, and (5) the willingness to realize ethically justified action. We illustrate their importance for teaching medical ethics using the example of teaching clinical ethics in medical studies.ConclusionOur conceptualization of moral–ethical competencies can be used to design concrete courses in a competency-oriented way. Our approach could be applied analogously to other areas of teaching ethics in health care. (shrink)
No categories
Außerklinische Ethikberatung: Eine Evaluation des Angebots in den Landkreisen Traunstein und Berchtesgadener Land mittels Dokumentenanalyse und Befragung von Hausärzten.Sandra Thiersch,Orsolya Friedrich &Georg Marckmann -2019 -Ethik in der Medizin 31 (1):45-59.detailsZusammenfassungWährend die Implementierung und Nutzung von Ethikberatung in deutschen Krankenhäusern in den letzten 20 Jahren vorangeschritten ist, entstehen erst in den letzten Jahren zunehmend Ethikberatungsangebote im außerklinischen Bereich. In den Landkreisen Traunstein und Berchtesgadener Land in Südost-Bayern wurde 2012 eine außerklinische Ethikberatung etabliert. Um im Rahmen einer ersten Evaluation wissenschaftliche Erkenntnisse über den Bedarf, die Inanspruchnahme und die Zufriedenheit mit diesem Beratungsangebot zu gewinnen, wurde eine Dokumentenanalyse und eine Fragebogenerhebung unter den Hausärzten der beiden Landkreise durchgeführt. Insgesamt nahmen 58 der (...) 195 angeschriebenen Hausärzte an der Umfrage teil.Die Auswertung der Dokumentation der außerklinischen Ethikberatung zeigte, dass die meisten Anfragen von betreuenden Angehörigen und aus Pflegeheimen kamen. Den Ergebnissen der Fragebogenerhebung zufolge sahen sich die Hausärzte mit vielfältigen ethischen Fragestellungen konfrontiert. Das Angebot einer ethischen Fallbesprechung zur Lösung dieser Konflikte wurde bislang jedoch nur von 17 Hausärzten in Anspruch genommen. Als Hauptgründe für die fehlende Nutzung des Angebots wurde der mangelnde Bekanntheitsgrad, der fehlende Bedarf und der organisatorische bzw. zeitliche Aufwand angeführt. Gleichzeitig äußerten Hausärzte, die eine ethische Fallbesprechung in Anspruch genommen haben, zu einem Großteil Interesse an einer erneuten Beratung und empfanden das Ergebnis der Ethikberatung als hilfreich. Damit verdeutlichen die Ergebnisse der Studie, dass Hausärzte zwar vielfältige ethische Fragestellungen in ihrem Arbeitsalltag wahrnehmen, aber bislang nur vergleichsweise selten ein externes Beratungsangebot zur Entscheidungsunterstützung in Betracht ziehen. (shrink)
No categories
Social Justice, Health Inequities, and Access to New Age-Related Interventions.Hans-Jörg Ehni &Georg Marckmann -2009 -Medicine Studies 1 (3):281-295.detailsSocial Justice, Health Inequities, and Access to New Age-Related Interventions Content Type Journal Article Category Original Paper Pages 281-295 DOI 10.1007/s12376-009-0027-3 Authors Hans-Jörg Ehni, University of Tuebingen, Tuebingen, Baden-Württemberg Germany Georg Marckmann, University of Tuebingen, Tuebingen, Baden-Württemberg Germany Journal Medicine Studies Online ISSN 1876-4541 Print ISSN 1876-4533 Journal Volume Volume 1 Journal Issue Volume 1, Number 3.
Old wine in new bottles? Ethical implications of individualized medicine.Sebastian Schleidgen &Georg Marckmann -2013 -Ethik in der Medizin 25 (3):223-231.detailsDie sogenannte individualisierte Medizin (IM) ist in den letzten Jahren zu einem Schlagwort in Wissenschaft, Politik und Öffentlichkeit geworden. Wie jede technologische Neuentwicklung hat sie jedoch (potentielle) ethische Implikationen, die es zu berücksichtigen gilt, um eine angemessene Entwicklung und Anwendung individualisierter Präventions- und Therapiemaßnahmen zu ermöglichen. Allerdings steht eine ethische Bewertung der IM vor verschiedenen methodischen Herausforderungen, die sich insbesondere aus der Heterogenität des Problembereichs, begrifflicher Unklarheit sowie dem Frühstadium ihrer Entwicklung ergeben. Der vorliegende Beitrag spezifiziert zunächst den Begriff der (...) IM, um den Kontext der weiteren Überlegungen einzugrenzen. Anschließend wird eine heuristisch zu verstehende Typologie (möglicher) individual- und sozialethischer Implikationen der IM entwickelt. Sie verdeutlicht, dass die IM vorwiegend ethische Probleme aufwirft, die aus anderen biomedizinischen Bereichen bekannt sind. Welche dieser Probleme tatsächlich relevant sind, ist allerdings abhängig von der jeweils spezifischen IM-Maßnahme. Eine adäquate ethische Bewertung kann daher nur durch die Evaluation jedes einzelnen individualisierten Ansatzes erfolgen. (shrink)
How do we want to grow old? Anti‐ageing‐medicine and the scope of public healthcare in liberal democracies.Mark Schweda &Georg Marckmann -2012 -Bioethics 27 (7):357-364.detailsHealthcare counts as a morally relevant good whose distribution should neither be left to the free market nor be simply imposed by governmental decisions without further justification. This problem is particularly prevalent in the current boom of anti-ageing medicine. While the public demand for medical interventions which promise a longer, healthier and more active and attractive life has been increasing, public healthcare systems usually do not cover these products and services, thus leaving their allocation to the mechanisms of supply and (...) demand on the free market. This situation raises the question on which basis the underlying preferences for and claims to a longer, healthier life should be evaluated. What makes anti-ageing medicine eligible for public funding? In this article, we discuss the role of anti-ageing medicine with regard to the scope and limits of public healthcare. We will first briefly sketch the basic problem of justifying a particular healthcare scheme within the framework of a modern liberal democracy, focusing on the challenge anti-ageing interventions pose in this regard. In the next section, we will present and discuss three possible solutions to the problem, essentialistic, transcendental, and procedural strategies of defining the scope of public healthcare. We will suggest a procedural solution adopting essentialistic and transcendental elements and discuss its theoretical and practical implications with regard to anti-ageing medicine. (shrink)
Präventionsmaßnahmen im Spannungsfeld zwischen individueller Autonomie und allgemeinem Wohl.Georg Marckmann -2010 -Ethik in der Medizin 22 (3):207-220.detailsAngesichts der Zunahme chronischer Erkrankungen erscheint es geboten, vermehrt auf Präventionsmaßnahmen zurückzugreifen, die den Einzelnen zu einer gesundheitsfördernden Lebensweise anhalten und exogene gesundheitsschädigende Einflüsse reduzieren. Dabei ergeben sich zwei ethische Problemkonstellationen: 1) Welche Einschränkungen der Entscheidungsautonomie des Einzelnen sind gerechtfertigt, um bestimmte Präventionsziele zu erreichen? 2) Welche Verantwortung kann und soll der Einzelne für seine Gesundheit tragen? Fünf ethische Anforderungen sind an jede Präventionsmaßnahme zu stellen: 1) nachgewiesene Wirksamkeit, 2) günstiges Kosten-Nutzen-Profil, 3) akzeptables Kosten-Nutzen-Verhältnis, 4) möglichst geringe Restriktivität und 5) (...) faire Entscheidungsverfahren. Je nachdem, wie weit diese Anforderungen erfüllt sind, lässt sich eine unterschiedlich starke Beeinflussung der individuellen Entscheidungsautonomie rechtfertigen. Anstatt den Einzelnen für gesundheitsschädigendes Verhalten retrospektiv zu bestrafen, sollte er – im Sinne einer Stärkung der Gesundheitsmündigkeit – prospektiv in die Lage versetzt werden, Sorge für seine eigene Gesundheit zu tragen. (shrink)
The Eurotransplant Kidney Allocation Algorithm–Moral Consensus or Pragmatic Compromise?Georg Marckmann -2001 -Analyse & Kritik 23 (2):271-279.detailsThe selection and balancing of values for the Eurotransplant kidney allocation algorithm poses both practical and ethical challenges. The paper argues that any allocation algorithm can only be justified by reference to some substantive conception of a good life that reflects our value preferences regarding the allocation of scarce donor kidneys. It is concluded that the criterion of HLA compatibility maximizes overall rather than individual utility. The paper emphasizes that good pragmatic arguments for maintaining the primacy of HLA matching can (...) never replace a more systematic, independent ethical justification. As neither the selection nor the balancing of the different allocation criteria are based on an explicit ethical justification, the paper concludes that the choice of the Wujciak-algorithm was rather a product of pragmatic compromise than moral consensus. (shrink)
How can physicians make cost-conscious treatment decisions in an ethically justified manner? A stepwise model.Georg Marckmann &Jürgen in der Schmitten -2011 -Ethik in der Medizin 23 (4):303-314.detailsTrotz aller Rationalisierungsbemühungen werden sich Leistungseinschränkungen im deutschen Gesundheitswesen nicht vermeiden lassen. Zwar sollten diese so weit möglich oberhalb der individuellen Arzt-Patient-Beziehung erfolgen, aus pragmatischen Gründen wird es sich aber nicht vermeiden lassen, dass Ärzte auch im Einzelfall Verantwortung für die Kosten ihrer Entscheidungen übernehmen, wie es bereits heute häufig der Fall ist. Der vorliegende Beitrag widmet sich deshalb der Frage, wie Ärzte in einer medizinisch rationalen und ethisch vertretbaren Art und Weise Kostenerwägungen in ihren Entscheidungen berücksichtigen können. Vorgeschlagen wird (...) ein vierstufiges Modell eines „ethischen Kostenbewusstseins“: 1) Unterlassung ineffektiver Maßnahmen im Sinne einer evidenzbasierten Medizin; 2) konsequente Berücksichtigung individueller Patientenpräferenzen; 3) Minimierung des diagnostischen und therapeutischen Aufwands für die Erreichung eines bestimmten Therapieziels; und 4) Verzicht auf teure Maßnahmen mit einem geringen/fraglichen Nutzengewinn für den Patienten. Stufen (1–3) sind durch die Prinzipien Wohltun, Nichtschaden und Respekt der Autonomie ethisch begründet, Stufe (4) durch das Prinzip der Gerechtigkeit. Für Entscheidungen auf der vierten Stufe sollten nach Möglichkeit lokale explizite Vorgaben wie z. B. kostensensible Leitlinien erarbeitet werden. Prozedurale Mindeststandards sind zu berücksichtigen, regelmäßige Kosten-Fallbesprechungen oder klinische Ethikberatung sollten zur Entscheidungsunterstützung verfügbar sein. Abschließend wird ein ethischer Algorithmus zur Abklärung des Einsatzes einer kostspieligen medizinischen Maßnahme vorgestellt. (shrink)
Organ Transplantation in Times of Donor Shortage: Challenges and Solutions.Galia Assadi,Ralf J. Jox &Georg Marckmann (eds.) -2016 - Cham: Imprint: Springer.detailsThis book analyzes the reasons for organ shortage and ventures innovative ideas for approaching this problem. It presents 29 contributions from a highly interdisciplinary group of world experts and upcoming professionals in the field. Every year thousands of patients die while waiting for organ transplantation. Health authorities, medical professionals and bioethicists worldwide point to the urgent and yet unsolved problem of organ shortage, which will be even intensified due to the increasing life expectancy. Even though the practical problem seems to (...) be well known, the search for suitable solutions continues and often restricts itself by being limited through disciplinary and national borders. Combining philosophical reflection with empirical results, this volume enables a unique insight in the ethics of organ transplantation and offers fresh ideas for policymakers, health care professionals, academics, and the general public. (shrink)
No categories
Teaching science vs. the apprentice model â do we really have the choice?Georg Marckmann -2001 -Medicine, Health Care and Philosophy 4 (1):85-89.detailsThe debate about the appropriate methodology of medical education has been (and still is) dominated by the opposing poles of teaching science versus teaching practical skills. I will argue that this conflict between scientific education and practical training has its roots in the underlying, more systematic question about the conceptual foundation of medicine: how far or in what respects can medicine be considered to be a science? By analyzing the epistemological status of medicine I will show that the internal aim (...) of medicine( promoting health through the prevention and treatment of disease ) differs from the internal aim of science ( the methodological and systematic acquisition of knowledge ). Therefore, medicine as a whole discipline should not be considered as a science. However, medicine can be conceptually and methodologically scientific in so much as it is based on scientific knowledge. There is evidence from cognitive science research that diagnostic reasoning not only relies on the application of scientific knowledge but also â especially in routine cases â on a process of pattern recognition, a reasoning strategy based on the memory of previously encountered patients. Hence, medical education must contain both: the imparting of scientific knowledge and the rich exposure to concrete cases during practical training. Hence, the question of teaching science vs. the apprentice model will not be either-or but rather both â but in which proportion? (shrink)
Gesundheit und Gerechtigkeit.Georg Marckmann -2011 - In Ralf Stoecker, Christian Neuhäuser & Marie-Luise Raters,Handbuch Angewandte Ethik. Stuttgart: Verlag J.B. Metzler. pp. 709-717.detailsGerechtigkeitGerechtigkeitund GesundheitimGesundheitund Gerechtigkeit Zusammenhang mit Gesundheit und Krankheit wird meist im Hinblick auf die Verteilung knapper Mittel in der Gesundheitsversorgung diskutiert. Diese Betrachtung greift jedoch insoweit zu kurz, als der Gesundheitszustand eines Menschen nur zum Teil vom Zugang zur medizinischen Versorgung abhängt. Andere Faktoren wie Bildung, Arbeitsbedingungen, sozialer Status, Umweltqualität und nicht zuletzt das individuelle Verhalten spielen eine mindestens ebenso wichtige Rolle für die Gesundheit der Menschen.
No categories
Introduction: Ethics of Information Technology in Health Care.Georg Marckmann &Kenneth Goodman -2006 -International Review of Information Ethics 5:2-5.detailsComputer-based information and communication technologies continue to transform the delivery of health care and the conception and scientific understanding of the human body and the diseases that afflict it. While information technology has the potential to improve the quality and efficiency of patient care, it also raises important ethical and social issues. This IRIE theme issue seeks to provide a forum to identify, analyse and discuss the ethical and social issues raised by various applications of information and communication technology in (...) medicine and health care. The contributions give a flavour of the extraordinarily broad landscape shaped by the intersection of medicine, computing and ethics. In fact, their diversity suggests that much more work is needed to clarify issues and approaches, and to provide practical tools for clinicians. (shrink)
What does it take to consent to islet cell xenotransplantation?: Insights from an interview study with type 1 diabetes patients and review of the literature.Georg Marckmann,Jochen Seissler,Barbara Ludwig,Sandra Thiersch &Johannes Kögel -2021 -BMC Medical Ethics 22 (1):1-11.detailsBackgroundThe transplantation of porcine islet cells provides a new potential therapy to treat patients with type 1 diabetes mellitus (T1DM). Compared to other biomedical technologies, xenotransplantation stands out in terms of its involvement of animals as graft sources, as well as the possible transmission of infectious diseases. As these aspects are especially relevant for potential xenotransplantation recipients, it is important to assess their opinion regarding this technology, in particular in terms of the requirements that should be met in the informed (...) consent process for xenotransplantation.MethodsWe conducted qualitative interviews with seven T1DM patients to assess their information needs prior to xenotransplantation. Before the interview, the participants received a model informed consent form for a clinical trial with porcine islet cells transplantation. The interviews were transcribed and analysed using qualitative content analysis.ResultsIn the interviews, we identified several requirements that are crucial for patients with T1DM in order to consider xenotransplantation as a potential treatment option: therapy-related requirements, professional care and supervision, successful behaviour and attitude management, improving quality of life, and managing control/self-determination challenges. Regarding the informed consent form, several of the participants’ questions remained open and should be addressed in more detail. The interviewees stressed the importance of personal consultations.ConclusionsTo become a sustainable therapeutic option, patients especially expected an improved diabetes control and a reduction of diabetes-related burdens. Health-related aspects prove to be pivotal for diabetic patients when considering porcine islet cell transplantation. The use of pigs as source for organ retrievals was not considered as problematic. (shrink)
Welche Rolle spielen ethische Theorien bei der ethischen Bewertung von Forschungsvorhaben?Georg Marckmann -2019 - In Monika Bobbert & Gregor Scherzinger,Gute Begutachtung?: Ethische Perspektiven der Evaluation von Ethikkommissionen Zur Medizinischen Forschung Am Menschen. Springer Fachmedien Wiesbaden. pp. 87-99.detailsDer ethische Methodenpluralismus stellt für die Begutachtungspraxis von Ethikkommissionen kein unüberwindbares Problem dar. Vielmehr stellt gerade die Pluralität moralischer Überzeugungssysteme in einer Gesellschaft eine Rechtfertigungsgrundlage für die normative Aktivität von Ethikkommissionen dar. So bietet insbesondere der Kohärentismus zur Spezifizierung und Abwägung normativer Prinzipien eine angemessene Methodik.
No categories
Mind the Gap: How Should We Translate Specific Ethical Norms Into Interventions?Niels Nijsingh,Bianca Jansky,Georg Marckmann &Katja Kuehlmeyer -2020 -American Journal of Bioethics 20 (4):89-91.detailsVolume 20, Issue 4, May 2020, Page 89-91.
Relevance of a normative framework for evaluating the impact of clinical ethics support services in healthcare.Oliver Rauprich,Georg Marckmann &Jan Schildmann -2022 -Journal of Medical Ethics 48 (12):987-988.detailsEvaluating the impact of clinical ethics support services remains a challenging task. 1 Against this background, we applaud the authors for developing a theoretical framework that aims to explain how repeated moral case deliberations may promote ‘practical wisdom’ in healthcare professionals and improve the quality of care in health facilities. 2 In our view, it is of particular value to draw attention to the learning processes that may be induced by ethics support services. Understanding such learning processes on the individual (...) and organisational level is a prerequisite for longitudinal research designs that may be suitable to study the impact of specific ethics support services on criteria deemed relevant in patient care. 3 In our comment, we would like to focus on one aspect, which we deem necessary to be able to explain the possible impact of ethics support on the quality of healthcare. This is the... (shrink)
Making substituted judgments: an interview study among clinicians.Andreas Schaider,Gian Domenico Borasio,Georg Marckmann &Ralf J. Jox -2015 -Ethik in der Medizin 27 (2):107-121.detailsZusammenfassungEin Großteil der medizinisch und ethisch schwierigen Therapieentscheidungen betrifft kritisch kranke, einwilligungsunfähige Patienten und wird auf Basis des mutmaßlichen Patientenwillens getroffen. Das Gesetz kann hierzu nur allgemeine Vorgaben geben. Es ist für die behandelnden Ärzte essentiell, sich ein konkretes Vorgehen zu erarbeiten. Wie in der Praxis vorgegangen wird, ist bisher kaum untersucht. Ziel dieser Studie ist es, die Vielfalt der Herangehensweisen und Erfahrungen von Klinikern zum mutmaßlichen Patientenwillen zu erforschen. Wir führten semistrukturierte Interviews mit 18 Ärzten und elf Pflegekräften von (...) intensiv- und palliativmedizinischen Abteilungen eines Universitätsklinikums durch. Die Abschriften der Tonaufnahmen wurden mithilfe der Qualitativen Datenanalyse ausgewertet. Auf einer numerischen Ratingskala wurde erhoben, wie hilfreich die Kliniker das Konzept des mutmaßlichen Willens fanden. Die meisten Studienteilnehmer hielten das Konzept des mutmaßlichen Willens für sehr hilfreich. Zu ihrem Vorgehen berichteten sie, dass sie zumeist die nächsten Angehörigen befragen, zuweilen auch Professionelle und falls möglich die Patienten selbst. Gefragt werde nach früheren Äußerungen der Patienten, nach ihrer Lebenspraxis und -einstellung sowie ihrem aktuellen Verhalten. Benannt wurden auch zahlreiche Unsicherheiten und Schwierigkeiten psychologischer, sozialer, praktischer und konzeptioneller Natur. Der mutmaßliche Patientenwille wird, so unser Ergebnis, in der von uns untersuchten klinischen Praxis entsprechend den gesetzlichen Vorgaben ermittelt. Da jedoch zahlreiche Probleme berichtet werden, stellen wir konkrete Empfehlungen zur Ermittlung des mutmaßlichen Willens vor. (shrink)
Between therapy and wish fulfillment: anti-aging medicine and the scope of public healthcare.Mark Schweda &Georg Marckmann -2012 -Ethik in der Medizin 24 (3):179-191.detailsDie wachsende Nachfrage nach Anti-Aging-Medizin wirft die Frage auf, welche medizinischen Leistungen ein solidarisches Gesundheitssystem tragen sollte. Die deutsche Entscheidungspraxis beruft sich auf den Begriff der Krankheit. Im Blick auf Anti-Aging wäre demnach 1) zu klären, was der Krankheitsbegriff bedeutet, 2) zu prüfen, ob das Altern sich unter diesen Begriff subsumieren lässt, um 3) abzuleiten, inwieweit Anti-Aging-Maßnahmen zur Verfügung zu stellen sind. Dieses Prozedere führt jedoch zu keinem brauchbaren Ergebnis. Unter Berufung auf den Krankheitsbegriff allein ist der Umfang solidarischer Gesundheitsversorgung (...) nicht zu bestimmen. Allerdings lässt sich durch Reflexion auftretender Probleme ein gangbarer Entscheidungsweg aufzeigen. Er sieht eine faire Verständigung über die Frage vor, wie wir alt werden wollen. (shrink)
Ethics in Public Health and Health Policy: Concepts, Methods, Case Studies.Daniel Strech,Irene Hirschberg &Georg Marckmann (eds.) -2013 - Dordrecht: Springer.detailsFaden, R. & Shebaya, S, Public Health Ethics. The Stanford Encyclopedia of Philosophy (Summer 2010 Edition), Edward N. Zalta (ed.). Available from: htt : lato.stanford.edu archives sum2010 entries ublichealth-ethics (accessed ...